Repligen raises $120M follow-on

On June 27, bioprocessing company Repligen Corp. (NASDAQ:RGEN) raised $120 million through the sale of 2.8 million shares at $42.75 in a follow-on underwritten by JPMorgan, Stephens, Janney Montgomer...